Consun Pharmaceutical Group Management
Management criteria checks 3/4
Consun Pharmaceutical Group's CEO is Meng An, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is CN¥19.79M, comprised of 5.5% salary and 94.5% bonuses, including company stock and options. directly owns 2.74% of the company’s shares, worth HK$186.80M. The average tenure of the management team and the board of directors is 4 years and 4 years respectively.
Key information
Meng An
Chief executive officer
CN¥19.8m
Total compensation
| CEO salary percentage | 5.5% |
| CEO tenure | less than a year |
| CEO ownership | 2.7% |
| Management average tenure | 4yrs |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story
Oct 02
Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors
Sep 26Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
Jun 12Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30
May 12Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30
Jun 01Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
May 04Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20
Apr 28Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20
Apr 07Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10
Aug 26Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly
Apr 21Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?
Mar 17Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative
Feb 19How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 29Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?
Jan 08
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly
Dec 18Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?
Nov 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥836m |
| Mar 31 2024 | n/a | n/a | CN¥810m |
| Dec 31 2023 | CN¥20m | CN¥1m | CN¥785m |
| Sep 30 2023 | n/a | n/a | CN¥759m |
| Jun 30 2023 | n/a | n/a | CN¥734m |
| Mar 31 2023 | n/a | n/a | CN¥708m |
| Dec 31 2022 | CN¥17m | CN¥1m | CN¥683m |
| Sep 30 2022 | n/a | n/a | CN¥660m |
| Jun 30 2022 | n/a | n/a | CN¥636m |
| Mar 31 2022 | n/a | n/a | CN¥613m |
| Dec 31 2021 | CN¥14m | CN¥670k | CN¥590m |
Compensation vs Market: Meng's total compensation ($USD2.73M) is above average for companies of similar size in the Hong Kong market ($USD480.33K).
Compensation vs Earnings: Meng's compensation has been consistent with company performance over the past year.
CEO
Meng An (53 yo)
less than a year
Tenure
CN¥19,793,000
Compensation
Mr. Meng An serves as Executive Chairman of the Board at Consun Pharmaceutical Group Limited since July 9, 2021 and serves a sits Chief Executive Officer from January 17, 2024. Mr. An being the Chairman of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | less than a year | CN¥19.79m | 2.74% HK$ 186.8m | |
| Chief Scientist & Executive Director | 4yrs | CN¥742.00k | no data | |
| Assistant GM | 3.7yrs | CN¥774.00k | no data | |
| CFO & VP | 4.7yrs | no data | no data | |
| Assistant President | 4.8yrs | no data | no data | |
| Board Secretary | 10.6yrs | no data | no data | |
| Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd | 4yrs | no data | no data | |
| Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd | 4yrs | no data | no data |
4.0yrs
Average Tenure
53yo
Average Age
Experienced Management: 1681's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | 3.7yrs | CN¥19.79m | 2.74% HK$ 186.8m | |
| Chief Scientist & Executive Director | 11.9yrs | CN¥742.00k | no data | |
| Assistant GM | 3.7yrs | CN¥774.00k | no data | |
| Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd | 4yrs | no data | no data | |
| Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd | 4yrs | no data | no data | |
| Independent Non-Executive Director | 10.9yrs | CN¥200.00k | no data | |
| Independent Non Executive Director | 5.5yrs | CN¥200.00k | no data | |
| Non-Executive Director | 3.3yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
4.0yrs
Average Tenure
53yo
Average Age
Experienced Board: 1681's board of directors are considered experienced (4 years average tenure).